PILA PHARMA AB acquired TRPV1 antagonists from Ario Pharma Limited.
PILA PHARMA AB completed the acquisition of TRPV1 antagonists from Ario Pharma Limited on March 30, 2016.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.3 SEK | +11.69% |
|
+0.23% | +168.75% |
04-19 | Pila Pharma Appoints New CEO, Chief Scientific Officer | MT |
04-19 | Pila Pharma AB Announces Board and Management Appointments | CI |
1st Jan change | Capi. | |
---|---|---|
+168.75% | 9.65M | |
+55.32% | 815B | |
-6.75% | 352B | |
+13.56% | 314B | |
+10.68% | 303B | |
+16.57% | 242B | |
+2.04% | 224B | |
+13.31% | 218B | |
+8.48% | 168B | |
-2.81% | 159B |